Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Wikipedia Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Habitual use of glucosamine and adverse liver outcomes among patients with type 2 diabetes and MASLD

Article in Liver International (June 2024)

Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease

Article in Hormones (March 2024)

Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update

Article in Clinical Nutrition (January 2024)